日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Engineered probiotics for tumor-targeted combination chemoimmunotherapy

用于肿瘤靶向联合化疗免疫疗法的工程化益生菌

Yang, Zaofeng; Im, Jongwon; Chen, Noah; Mariuzza, Dylan L; de Los Santos-Alexis, Kenia; Li, Fangda; Danino, Tal; Arpaia, Nicholas

Structural insights into clonal restriction and diversity in T cell recognition of two immunodominant SARS-CoV-2 nucleocapsid epitopes

从结构角度揭示T细胞识别两种免疫优势SARS-CoV-2核衣壳表位的克隆限制和多样性

Yuan, Ping; Chen, Guodong; Li, Yukun; Liu, Xichun; Saravanakumar, Shayana; Zhao, Jianfeng; Ji, Qianyu; Wang, Hong; Lin, Ying-Wu; Elbahnasawy, Mostafa; Weng, Nan-Ping; Pierce, Brian G; Mariuzza, Roy A; Wu, Daichao

Recognition of Self and Viral Ligands by NK Cell Receptors

NK细胞受体对自身配体和病毒配体的识别

Mariuzza, Roy A; Singh, Pragya; Karade, Sharanbasappa S; Shahid, Salman; Sharma, Vijay Kumar

Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers.

利用二价 Fab 作为参考标记,确定了 HCV E2 糖蛋白与中和抗体和非中和抗体结合的冷冻电镜结构

Shahid Salman, Karade Sharanbasappa S, Hasan S Saif, Yin Rui, Jiang Liqun, Liu Yanxin, Felbinger Nathaniel, Kulakova Liudmila, Toth Eric A, Keck Zhen-Yong, Foung Steven K H, Fuerst Thomas R, Pierce Brian G, Mariuzza Roy A

Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicity

丙型肝炎病毒E2糖蛋白的糖基化工程改造可改善其生化特性并增强其免疫原性

Kulakova, Liudmila; Li, Kiki H; Chiang, Austin W T; Schwoerer, Michael P; Schoffelen, Sanne; Elkholy, Khadija; Chao, Kinlin L; Shahid, Salman; Kumar, Bhoj; Murray, Nathan B; Archer-Hartmann, Stephanie; Azadi, Parastoo; Voldborg, Bjørn G; Marin, Alexander; Mariuzza, Roy A; Andrianov, Alexander K; Ploss, Alexander; Lewis, Nathan E; Toth, Eric A; Fuerst, Thomas R

Programmable bacteria synergize with PD-1 blockade to overcome cancer cell-intrinsic immune resistance mechanisms

可编程细菌与PD-1阻断剂协同作用,克服癌细胞固有的免疫抵抗机制。

Fangda Li ,Zaofeng Yang ,Thomas M Savage ,Rosa L Vincent ,Kenia de Los Santos-Alexis ,Alexander Ahn ,Mathieu Rouanne ,Dylan L Mariuzza ,Tal Danino ,Nicholas Arpaia

Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigens

人T细胞受体识别NRAS癌症新抗原的结构表征和AlphaFold建模

Wu, Daichao; Yin, Rui; Chen, Guodong; Ribeiro-Filho, Helder V; Cheung, Melyssa; Robbins, Paul F; Mariuzza, Roy A; Pierce, Brian G

The immune checkpoint receptor LAG3: Structure, function, and target for cancer immunotherapy

免疫检查点受体LAG3:结构、功能及癌症免疫治疗靶点

Mariuzza, Roy A; Shahid, Salman; Karade, Sharanbasappa S

Cutting Edge: LAG3 Dimerization Is Required for TCR/CD3 Interaction and Inhibition of Antitumor Immunity

前沿研究:LAG3二聚化是TCR/CD3相互作用和抑制抗肿瘤免疫所必需的

Adam, Kieran; Lipatova, Zhanna; Abdul Ghafoor Raja, Maria; Mishra, Arjun K; Mariuzza, Roy A; Workman, Creg J; Vignali, Dario A A

Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigens

人类 T 细胞受体识别 NRAS 癌症新抗原的结构表征和 AlphaFold 建模

Daichao Wu, Rui Yin, Guodong Chen, Helder V Ribeiro-Filho, Melyssa Cheung, Paul F Robbins, Roy A Mariuzza, Brian G Pierce